Margenza 250 mg/10 mL (25 mg/mL) injection Images

Generic Name: margetuximab

This medication has been identified as Margenza 250 mg/10 mL (25 mg/mL) injection. It is supplied by MacroGenics, Inc.

Margenza is used in the treatment of Breast Cancer, Metastatic and belongs to the drug class HER2 inhibitors. Margenza 250 mg/10 mL (25 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Margenza

Generic Name

margetuximab

Strength

250 mg/10 mL (25 mg/mL) injection

Availability

Prescription only

Drug Class

HER2 inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

MacroGenics, Inc.

National Drug Code (NDC)

74527-0022

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer